In Silico Screening Patents (Class 506/8)
-
Publication number: 20150056620Abstract: The present invention provides methods of: identifying pathogens in biological samples from humans and animals, resolving a plurality of etiologic agents present in samples obtained from humans and animals, determining detailed genetic information about such pathogens or etiologic agents, and rapid detection and identification of bioagents from environmental, clinical or other samples.Type: ApplicationFiled: August 29, 2014Publication date: February 26, 2015Inventors: David J. Ecker, Richard H. Griffey, Rangarajan Sampath, Steven A. Hofstadler, John McNeil, Stanley T. Crooke, Lawrence B. Blyn, Raymond Ranken, Thomas A. Hall
-
Publication number: 20150051090Abstract: In one aspect, the invention relates to a method for identifying a small molecule which binds an evolved three dimensional topological feature on a target protein. In certain embodiments, the three dimensional topological feature evolves on the target protein as a result of binding by a biomolecule to the target protein. In certain embodiments, the small molecule modulates an activity of the target protein. In certain embodiments, the evolved three dimensional topological features are identified using molecular dynamics simulation.Type: ApplicationFiled: August 19, 2014Publication date: February 19, 2015Inventor: Yibing SHAN
-
Publication number: 20150023974Abstract: The present invention relates to the identification of a TLR2 binding epitope wherein binding of a binding member to the epitope serves to inhibit TLR2 activation and/or signalling. Polypeptide fragments of TLR2 and three-dimensional structures comprising one or more amino acid residues His318, Pro320, Gln321 or Arg321, Tyr323, Lys347, Phe349, Leu371, Glu375, Tyr376 and His398 of TLR2 which define the identified epitope are provided for use in generating binding members. Also provided are binding members which bind to the identified epitope and methods of using same for the treatment and/or prevention of conditions associated with TLR2 activation and/or signalling.Type: ApplicationFiled: March 29, 2013Publication date: January 22, 2015Inventors: Nils Kuklik, Wolf-Dieter Schubert
-
Publication number: 20150024951Abstract: Methods for identifying disease-related pathways that can be used to identify drug discovery targets, to identify new uses for known drugs, to identify markers for drug response, and related purposes.Type: ApplicationFiled: July 28, 2014Publication date: January 22, 2015Inventors: Richard O. CHEN, Raymond J. CHO, Ramon M. FELCIANO, Bret HOLLEY, Viresh PATEL, Daniel R. RICHARDS, Sushma SELVARAJAN, Keith STEWARD, Sara Tanenbaum SCHNEIDER
-
Publication number: 20150023949Abstract: Methods for treatment and diagnosis of pervasive developmental disorders in humans are described.Type: ApplicationFiled: March 5, 2013Publication date: January 22, 2015Inventors: Niven Rajin Narain, Paula Patricia Narain
-
Publication number: 20150011620Abstract: The present invention relates to the field of anti-invasive compounds and methods for predicting the anti-invasive activity of said compounds, as well as their use in the prevention and/or treatment of diseases associated with undesired cell invasion; in particular, this invention relates to the field of anti-invasive chalcone-like compounds.Type: ApplicationFiled: January 30, 2013Publication date: January 8, 2015Inventors: Marc Bracke, Christian Stevens, Tine De Ryck, Bart Roman, Barbara Vanhoecke
-
Publication number: 20140371079Abstract: Cancer-targeting peptides having a PX1LX2 motif, in which X1 is His or an amino acid residue with a hydrophobic side chain and X2 is Pro, Phe, or Trp. Also disclosed herein are conjugates containing the cancer-targeting peptides and uses thereof in cancer treatment and diagnosis.Type: ApplicationFiled: August 13, 2014Publication date: December 18, 2014Inventors: John Yu, Alice L. Yu, H.C. Wu, I-Ju Chen, Sheng-hung Wang
-
Publication number: 20140364434Abstract: Methods and systems for identifying a cancer patient suitable for treatment with a PARP inhibitor. A 6-gene, 7-gene and 8-gene predictor panels of genes that are predictive of patient resistance or sensitivity to PARP inhibitors such as Olaparib.Type: ApplicationFiled: June 6, 2014Publication date: December 11, 2014Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Anneleen Daeman, Denise M. Wolf, Laura J. Van 't Veer, Paul T. Spellman, Joe W. Gray
-
Publication number: 20140351962Abstract: The present invention provides a method of testing a dog to determine the susceptibility of the dog to liver copper accumulation, comprising detecting in a sample the presence or absence in the genome of the dog of one or more polymorphisms selected from: (a) Chr22_3167534 (SEQ ID NO: 144), Chr22_3135144 (SEQ ID NO: 145), Chr20_55461150 (SEQ ID NO: 146), ChrX_120879711 (SEQ ID NO: 147), Chr19_6078084 (SEQ ID NO: 148), Chr15_62625262 (SEQ ID NO: 149), Chr14_39437543 (SEQ ID NO: 150), Chr15_62625024 (SEQ ID NO: 151), Chr3_86838677 (SEQ ID NO: 152), Chr24_4011833 (SEQ ID NO: 153), Chr18_60812198 (SEQ ID NO: 154), Chr10_65209946 (SEQ ID NO: 155), and the CGCCCC repeat at chromosome location 22:3135287; (b) one or more polymorphisms in linkage disequilibrium with a said polymorphism (a); and/or (c) Chr32_38904515 (SEQ ID NO: 156), Chr8_4892743 (SEQ ID NO: 157) and Chr8_4880518 (SEQ ID NO: 158).Type: ApplicationFiled: December 6, 2012Publication date: November 27, 2014Applicant: MARS, INC.Inventors: Alan James Martin, Paul Glyn Jones, Adrian Watson, Jan Rothuizen, Hille Fieten, Pieter Antonius Jozef Leegwater
-
Publication number: 20140328838Abstract: A method of producing a non-immunogenic immunoglobulin for administration to a target species is provided wherein the method comprises substituting amino acid residues in framework regions of a donor immunoglobulin with amino acid residues present at a corresponding position in framework regions of at least one immunoglobulin derived from the target species. Also provided are antibodies produced by the method of the invention, including novel humanised and caninised anti-NGF antibodies. The invention extends to nucleic acids encoding same and to methods of treating pain and arthritis in a human or dog using said antibodies and/or nucleic acids.Type: ApplicationFiled: September 5, 2012Publication date: November 6, 2014Inventor: David Gearing
-
Publication number: 20140315742Abstract: The present invention relates to methods and kits to assess an absorbed dose of ionizing radiation and/or the severity of tissue injury from radiation in a patient. The invention also relates to algorithms used to calculate an absorbed dose of radiation based on biomarker measurements of a plurality of biomarkers that are altered relative to a normal control in the event of radiation exposure.Type: ApplicationFiled: September 28, 2012Publication date: October 23, 2014Applicants: MESO SCALE TECHNOLOGIES, LLC, THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.Inventors: William F Blakely, Eli N. Glezer, John Kenten, Sudeep Kumar, Anu Mathew, Natalia I. Ossetrova, George Sigal
-
Publication number: 20140315731Abstract: Methods and systems for evaluating biological dataset profiles relating to toxic agents including candidate pharmaceuticals, environmental agents, biowarfare and chemical warfare agents are provided, where datasets comprising information for multiple cellular parameters are compared and identified, and used in the evaluation of candidate agents.Type: ApplicationFiled: April 21, 2014Publication date: October 23, 2014Applicant: DISCOVERX CORPORATIONInventor: Ellen L. Berg
-
Publication number: 20140309122Abstract: Systems and methods are disclosed for Knowledge-Driven Sparse Learning to Identify Interpretable High-Order Feature Interactions. This is done by generating one or more functional groups from gene features and gene and protein interaction grouping; selecting informative genes and functional interactions that exhibit differential patterns for the target disease and to generate a reduced feature space; and searching exhaustively on the reduced feature space by examining all possible pairs of interacting features (and possibly higher-order feature interactions) to identify combination of markers and complex patterns of feature interactions that are informative about the phenotypes in a sparse learning framework to select informative interactions and genes.Type: ApplicationFiled: April 3, 2014Publication date: October 16, 2014Applicant: NEC Laboratories America, Inc.Inventors: Renqiang Min, Yanjun Qi, Salim Akhter Chowdhury
-
Publication number: 20140309121Abstract: A method of categorising a human according to pre-determined categories using Matrix Assisted Laser Desorption Ionisation Mass Spectrometry (MALDI-MS) is disclosed. A method is provided to discriminate humans based on gender, for example, by comparing MALDI-MS sample spectral data in the m/z range 2,000 to 30,000 and comparing these sample spectral data with reference spectral data obtained from pre-categorised humans.Type: ApplicationFiled: July 24, 2012Publication date: October 16, 2014Inventors: Simona Francese, Leesa Susanne Ferguson, Rosalind Wolstenholme, Florian Wulfert, Judith Marlou Fonville
-
Publication number: 20140303011Abstract: The invention provides for a method for distinguishing spore preparation procedures using spore molecular signatures, the method comprising harvesting spores from a sample; extracting molecules from the spores, fractionating the extracted molecules for analysis; generating molecular signatures from the fractionated molecules, and comparing the molecular signatures to a library of molecular signatures.Type: ApplicationFiled: March 22, 2012Publication date: October 9, 2014Applicant: UCHICAGO ARGONNE, LLCInventors: Daniel Shabacker, Adam Driks
-
Publication number: 20140303069Abstract: Anti-microbial peptides and methods of use are provided.Type: ApplicationFiled: November 20, 2012Publication date: October 9, 2014Inventors: Guangshun Wang, Biswajit Mishra
-
Publication number: 20140303228Abstract: The disclosure provides biomarkers of amyotrophic lateral sclerosis (ALS). The disclosure also provides various methods of using the biomarkers, including methods for diagnosis of ALS, methods of determining predisposition to ALS, methods of monitoring progression/regression of ALS, methods of assessing efficacy of compositions for treating ALS, methods of screening compositions for activity in modulating biomarkers of ALS, methods of treating ALS, as well as other methods based on biomarkers of ALS.Type: ApplicationFiled: October 17, 2012Publication date: October 9, 2014Inventors: Kay A. Lawton, Meredith V. Brown, Bruce Neri, Rebecca Caffrey, Michael V. Milburn
-
Publication number: 20140296085Abstract: The present invention relates to biomarkers associated with breast cancer prognosis. These biomarkers include coding transcripts and their expression products, as well as non-coding transcripts, and are useful for predicting the likelihood of breast cancer recurrence in a breast cancer patient, The present invention also relates to a novel method of identifying intergenic sequences that correlate with a clinical outcome.Type: ApplicationFiled: November 2, 2012Publication date: October 2, 2014Applicant: GENOMIC HEALTH, INC.Inventors: Joffre B. Baker, Dominick S. Sinicropi, Robert J. Pelham, Michael R. Crager, Francois Collin, James C. Stephans, Mei-Lan Liu, John D. Morlan, Kunbin Qu
-
Publication number: 20140296081Abstract: Methods for creating a library of recurrently mutated genomic regions and for using the library to analyze cancer-specific and patient-specific genetic alterations in a patient are provided. The methods can be used to measure tumor-derived nucleic acids in patient blood and thus to monitor the progression of disease. The methods can also be used for cancer screening.Type: ApplicationFiled: March 13, 2014Publication date: October 2, 2014Inventors: Maximilian Diehn, Arash Ash Alizadeh, Aaron M. Newman, Scott V. Bratman
-
Publication number: 20140286964Abstract: The present invention provides methods for designing agents such as ligands capable of binding to a Janus kinase (Jak), particularly a Jak2 JH2, and especially a JH2 V617F, screening methods for identifying agents such as ligands and small molecules capable of binding to the same, and computer assisted methods for designing and identifying such agents. Further, the present invention provides methods for treating myeloproliferative neoplasias (MPNs) along with agents such as ligands and small molecules identified or designed using the methods described.Type: ApplicationFiled: October 24, 2012Publication date: September 25, 2014Inventors: Stevan R. Hubbard, Rajintha M. Bandarayanake, Olli Silvennoinen, Daniela Ungureanu
-
Publication number: 20140274751Abstract: Provided herein is technology relating to identifying unknown compounds and particularly, but not exclusively, to methods and systems for identifying unknown compounds by gas chromatography-mass spectrometry by use of retention index as a second dimension for identification.Type: ApplicationFiled: August 3, 2012Publication date: September 18, 2014Applicant: SMITHS DETECTION INC.Inventors: Charles Sadowski, Greger Andersson, Kevin Judge
-
Publication number: 20140274749Abstract: Methods for processing data using information gained from examining biological materials identifies and characterized probes for Single Nucleotide Polymorphisms and identifies Off Target Variants.Type: ApplicationFiled: March 15, 2013Publication date: September 18, 2014Inventor: Affymetrix, Inc.
-
Publication number: 20140274752Abstract: Disclosed are methods and tools for rapidly aligning reads to a reference sequence. These methods and tools employ Bloom filters or similar set membership testers to perform the alignment. The reads may be short sequences of nucleic acids or other biological molecules and the reference sequences may be sequences of genomes, chromosomes, etc. The Bloom filters include a collection of hash functions, a bit array, and associated logic for applying reads to the filter. Each filter, and there may be multiple of these used in a particular application, is used to determine whether an applied read is present in a reference sequence. Each Bloom filter is associated with a single reference sequence such as the sequence of a particular chromosome. In one example, chromosomal abundance is determined by aligning reads from a sequencer to multiple chromosomes, each having an associated Bloom filter or other set membership tester.Type: ApplicationFiled: October 18, 2012Publication date: September 18, 2014Inventors: Erich D. Blume, John P. Burke, Hui Huang
-
Publication number: 20140274750Abstract: The invention generally relates to sequence assembly and particularly to ordering the alignment of contigs to reference maps. The invention provides systems and methods for assembling contigs by aligning those contigs to a reference map in descending order of placement confidence. Each placement decreases the number of possible placements for the remaining contigs, which otherwise would have been likely to match in numerous places. Contigs are thereby placed along the reference genome with confidence and thus can be assembled into a genome-scale sequence assembly.Type: ApplicationFiled: March 14, 2014Publication date: September 18, 2014Applicant: OpGEN, INC.Inventor: Deacon John Sweeney
-
Publication number: 20140275088Abstract: In one aspect, the present invention relates to a method of identifying compounds useful in modifying the activity of Aldolase.Type: ApplicationFiled: October 25, 2012Publication date: September 18, 2014Inventors: Timothy J. Cardozo, Jürgen Bosch, Sondra Maureen Nemetski
-
Publication number: 20140249035Abstract: The present invention generally relates to methods of rapidly and efficiently searching biologically-related data space. More specifically, the invention includes methods of identifying bio-molecules with desired properties, or which are most suitable for acquiring such properties, from complex bio-molecule libraries or sets of such libraries. The invention also provides methods of modeling sequence-activity relationships. As many of the methods are computer-implemented, the invention additionally provides digital systems and software for performing these methods.Type: ApplicationFiled: April 18, 2014Publication date: September 4, 2014Applicant: Codexis Mayflower Holdings, LLCInventor: Richard John Fox
-
Publication number: 20140250546Abstract: The invention relates to efficient, high-throughput methods, systems, and DNA constructs for identification and isolation of terminator sequences causing enhanced transcription. The invention further relates to terminator sequences isolated with such methods and their use for enhancing gene expression.Type: ApplicationFiled: July 20, 2012Publication date: September 4, 2014Applicant: BASF PLANT SCIENCE COMPANY GMBHInventors: Julia Verena Hartig, Alrun Nora Burgmeier, Josef Martin Kuhn, Linda Patricia Loyall, Elke Duwenig
-
Publication number: 20140243221Abstract: Methods for identifying and/or distinguishing a homogeneous population of cells based on their replication domain timing profile using high resolution genomic arrays or sequencing procedures are provided. These methods may be used to compare the replication timing profile for a population of cells to another replication timing profile(s), a replication timing fingerprint, and/or one or more informative segments of a replication timing fingerprint, which may be simultaneously or previously determined and/or contained in a database, to determine whether there is a match between them. Based on such information, the identity of the population of cells may be determined, or the identity of the population of cells may be distinguished from other populations of cells or cell types. Methods for determining a replication timing fingerprint for particular cell types are also provided.Type: ApplicationFiled: May 2, 2014Publication date: August 28, 2014Applicant: FLORIDA STATE UNIVERSITY RESEARCH FOUNDATIONInventors: David M. GILBERT, Tyrone RYBA, Ichiro HIRATANI
-
Publication number: 20140243220Abstract: Described herein are methods for analyzing complex host-microbial mixtures. The disclosed methods may be used to diagnosis or prognose in a subject an inflammatory disease, which is caused by or contributed to by microbes.Type: ApplicationFiled: February 25, 2014Publication date: August 28, 2014Applicant: J. Craig Venter InstituteInventor: Rembert Pieper
-
Publication number: 20140221221Abstract: Provided herein are methods and systems of molecular profiling of diseases, such as cancer. In some embodiments, the molecular profiling can be used to identify treatments for a disease, such as treatments that were not initially identified as a treatment for the disease or not expected to be a treatment for a particular disease.Type: ApplicationFiled: February 7, 2014Publication date: August 7, 2014Applicant: Caris MPI, Inc.Inventors: Daniel D. Von Hoff, David M. Loesch, Arlet Alarcon, Robert J. Penny, Alan Wright, Matthew J. McGinniss, Ryan P. Bender, Traci Pawlowski
-
Publication number: 20140221222Abstract: Provided herein are methods and systems of molecular profiling of diseases, such as cancer. In some embodiments, the molecular profiling can be used to identify treatments for a disease, such as treatments that were not initially identified as a treatment for the disease or not expected to be a treatment for a particular disease.Type: ApplicationFiled: April 9, 2014Publication date: August 7, 2014Applicant: Caris MPI, Inc.Inventors: Daniel D. Von Hoff, David M. Loesch, Arlet Alarcon, Robert J. Penny, Alan Wright, Matthew J. McGinniss, Ryan P. Bender, Traci Pawlowski
-
Publication number: 20140220576Abstract: DNA taggants in which the nucleotide sequences are defined according to combinatorial mathematical principles. Methods of defining nucleotide sequences of the combinatorial DNA taggants, and using such taggants for authentication and tracking and tracing an object or process are also disclosed.Type: ApplicationFiled: April 14, 2014Publication date: August 7, 2014Applicant: JEANSEE LLCInventor: Anthony J. MACULA
-
Publication number: 20140213770Abstract: The present invention relates to improved methods for antibody engineering, e.g., humanization. In particular, the disclosure provides a high-throughput antibody humanization process that can be automated by computer-implementation.Type: ApplicationFiled: December 20, 2013Publication date: July 31, 2014Applicant: AbbVie, Inc.Inventors: Feng DONG, Jijie GU, Chung-Ming HSIEH
-
Publication number: 20140200148Abstract: An apparatus for glycan analysis is disclosed. The apparatus includes a plurality of loading wells adapted to receive a plurality of samples; a plurality of capillaries arranged in correspondence with the loading wells, each of the capillaries including a first portion including a stacking gel and a second portion including a resolving gel; and a plurality of eluting wells arranged in correspondence with the capillaries and adapted to receive a portion of the samples having traversed the capillaries.Type: ApplicationFiled: August 10, 2012Publication date: July 17, 2014Applicant: LIFE TECHNOLOGIES CORPORATIONInventor: Peter Slade
-
Publication number: 20140194299Abstract: Compositions, methods and related uses are provided relating to cleaving modified DNA. For example, a set of DNA fragments obtainable by enzymatic cleavage of a large DNA is described where at least 50% are similarly sized and have a centrally positioned modified nucleotide. In addition, an enzyme preparation is provided that includes one or more enzymes that recognize a modified nucleotide in a DNA and cleave the DNA at a site that is at a non-random distance from the modified nucleotide. The one or more enzymes are further characterized by an N-terminal conserved domain with greater than 90% amino acid sequence homology to WXD(X)10YXGD. The related uses include creating a methylome, methods of purifying DNA fragments containing a modified nucleotide and diagnostic applications.Type: ApplicationFiled: January 30, 2014Publication date: July 10, 2014Applicant: New England Biolabs, Inc.Inventors: YU ZHENG, RICHARD J. ROBERTS
-
Publication number: 20140179807Abstract: The present invention includes an apparatus, system and method for the development and use of transcriptional modules by obtaining individual gene expression levels from cells obtained from one or more patients with a disease or condition; recording the expression value for each gene in a table that is divided into clusters; iteratively selecting gene expression values for one or more transcriptional modules by: selecting for the module the genes from each cluster that match in every disease or condition; removing the selected genes from the analysis; and repeating the process of gene expression value selection for genes that cluster in a sub-fraction of the diseases or conditions; and iteratively repeating the generation of modules.Type: ApplicationFiled: October 17, 2013Publication date: June 26, 2014Applicant: Baylor Research InstituteInventors: Damien Chaussabel, Jacques Banchereau
-
Publication number: 20140179537Abstract: The present invention relates to methods and compositions for diagnosing, monitoring, prognosticating, analyzing, etc., polymicrobial diseases. The present invention also relates to the microbial community present in the digestive tract and lumen in normal subjects, and subjects with digestive tract diseases, especially diseases of the colon, such as inflammatory bowel disease, including ulcerative colitis, Crohn's syndrome, and pouchitis. The present invention especially relates to compositions and methods for diagnosing and prognosticating the mentioned diseases and conditions, e.g., to determine the presence of the disease in a subject, to determine a therapeutic regimen, to determine a therapeutic regimen, to determine the onset of active disease, to determine the predisposition to the disease, etc.Type: ApplicationFiled: November 25, 2013Publication date: June 26, 2014Applicants: Rush University, George Mason Intellectual Properties, Inc.Inventor: Patrick M. Gillevet
-
Publication number: 20140171332Abstract: The invention provides for carrying out 3-dimensional similarity searching by comparing a probe molecule to each member of a 3-dimensional database. The probe molecule is overlapped with each member of a database of molecules and then the database molecule is rotated and translates until its similarity with the probe molecule is maximized. The system can contain ten different scoring functions to rate the similarity between the two molecules. Each function employs different molecular features when scoring a particular comparison. Some methods are based on the relative shape of the two molecules, and some are based on the overlap of key atoms such as oxygen, nitrogen, sulfur, and/or halogens.Type: ApplicationFiled: December 5, 2013Publication date: June 19, 2014Applicant: Hudson Robotics, Inc.Inventors: Alan H. Katz, Philip J. Farrelly
-
Publication number: 20140162887Abstract: Methods and compositions for determining and/or predicting a response to a therapy, prognosis of a cancer subject or survival of a cancer and kits for performing the same are described herein.Type: ApplicationFiled: February 6, 2012Publication date: June 12, 2014Applicant: BIOARRAY THERAPEUTICS, INC.Inventors: Katherine J. Martin, Marcia V. Fournier
-
Publication number: 20140161721Abstract: This document provides methods and materials related to genetic variations of developmental disorders. For example, this document provides methods for using such genetic variations to assess susceptibility of developing Autism Spectrum Disorder.Type: ApplicationFiled: February 8, 2013Publication date: June 12, 2014Inventors: Eli Hatchwell, Peggy S. Eis, Stephen Scherer, Aparna Prasad
-
Patent number: 8741811Abstract: Biological samples including cell-free DNA fragments are analyzed to identify imbalances in chromosomal regions, e.g., due to deletions and/or amplifications in a tumor. Multiple loci are used for each chromosomal region. Such imbalances can then be used to diagnose (screen) a patient for cancer, as well as prognosticate a patient with cancer, or to detect the presence or to monitor the progress of a premalignant condition in a patient. The severity of an imbalance as well as the number of regions exhibiting an imbalance can be used. A systematic analysis of non-overlapping segments of a genome can provide a general screening tool for a sample. Additionally, a patient can be tested over time to track severity of each of one or more chromosomal regions and a number of chromosomal regions to enable screening and prognosticating, as well as monitoring of progress (e.g. after treatment).Type: GrantFiled: November 30, 2011Date of Patent: June 3, 2014Assignee: The Chinese University of Hong KongInventors: Yuk Ming Dennis Lo, Kwan Chee Chan, Wai Kwun Rossa Chiu, Peiyong Jiang
-
Publication number: 20140141981Abstract: The invention provides methods for simultaneously amplifying multiple nucleic acid regions of interest in one reaction volume as well as methods for selecting a library of primers for use in such amplification methods. The invention also provides library of primers with desirable characteristics, such as minimal formation of amplified primer dimers or other non-target amplicons.Type: ApplicationFiled: February 3, 2014Publication date: May 22, 2014Applicant: Natera, Inc.Inventors: Bernhard Zimmermann, Matthew Hill, Philippe Lacroute, Michael Dodd
-
Publication number: 20140121121Abstract: A system and method for determining individualized medical intervention for a particular disease state, and especially for cancers, that includes the molecular profiling of a biological sample from the patient, determining whether any molecular findings including one or more genes, one or more gene expressed proteins, one or more molecular mechanisms, and/or combinations of such exhibit a change in expression compared to a reference, and identifying a non-specific disease therapy or agent capable of interacting with the genes, gene expressed proteins, molecular mechanisms, or combinations of such molecular findings that exhibited a change in expression.Type: ApplicationFiled: January 8, 2014Publication date: May 1, 2014Applicant: Caris MPI, Inc.Inventors: Daniel D. Von Hoff, Robert J. Penny
-
Publication number: 20140121120Abstract: Methods for identifying disease-related pathways that can used to identify drug discovery targets, to identify new uses for known drugs, to identify markers for drug response, and related purposes.Type: ApplicationFiled: June 10, 2013Publication date: May 1, 2014Applicant: Ingenuity Systems, Inc.Inventors: Richard O. Chen, Raymond J. Cho, Ramon M. Felciano, Bret Holley, Viresh Patel, Daniel R. Richards, Sushma Selvarajan, Keith Steward, Sara Schneider
-
Publication number: 20140113829Abstract: Systems and methods of selecting combinatorial coordinately dysregulated biomarker subnetworks are provided. In one embodiment, a method comprises comparing the normalized gene expression data to a predetermined threshold to provide binary gene expression data associated with phenotype samples and control samples, analyzing subnetwork states of the binary gene expression data associated with phenotype samples and control samples to identify gene expression patterns that occur in phenotype samples and do not occur in control samples and identifying a subnetwork that provides gene expression patterns indicative of a sample being a phenotype sample.Type: ApplicationFiled: April 22, 2011Publication date: April 24, 2014Applicant: CASE WESTERN RESERVE UNIVERSITYInventors: Mehmet Koyuturk, Mark Chance, Rod Nibbe, Salim Akhter Chowdhury
-
Publication number: 20140066320Abstract: Described herein are technologies pertaining to computationally-efficiently performing genome-wide association studies. Feature selection methods are used to identify genetic markers for addressing potential confounding in the data. Then, single SNPs, or groups of genetic markers are analyzed to ascertain whether such groups are causal or tagging of causal as to a specified phenotype, after taking in to account the feature-selected SNPs. Group and univariate analysis is accomplished by way of analyzing a group of genetic markers conditioned upon other genetic markers that are found to be predictive of the specified phenotype.Type: ApplicationFiled: September 4, 2012Publication date: March 6, 2014Applicant: MICROSOFT CORPORATIONInventors: David Earl Heckerman, Jennifer Listgarten, Christoph Anthony Lippert, Jing Xiang, Nicolo Fusi, Carl M. Kadie, Robert I. Davidson
-
Publication number: 20140066321Abstract: Provided are histidyl-tRNA synthetase variant polypeptides, X-ray crystallographic and NMR spectroscopy structures of HRS polypeptides, and related compositions and methods for therapy and drug discovery.Type: ApplicationFiled: July 23, 2013Publication date: March 6, 2014Applicants: aTyr Pharma, Inc.Inventors: Zhiwen Xu, Zhiyi Wei, Xiang-Lei Yang, Mingjie Zhang, Paul Schimmel
-
Publication number: 20140051137Abstract: A group of bacterial dihydroxy-acid dehydratases having a [2Fe-2S] cluster was discovered. Bacterial [2Fe-2S] DHADs were expressed as heterologous proteins in bacteria and yeast cells, providing DHAD activity for conversion of 2,3-dihydroxyisovalerate to ?-ketoisovalerate or 2,3-dihydroxymethylvalerate to ?-ketomethylvalerate. Isobutanol and other compounds may be synthesized in pathways that include bacterial [2Fe-2S] DHAD activity.Type: ApplicationFiled: March 15, 2013Publication date: February 20, 2014Applicant: Butamax(TM) Advanced Biofuels LLCInventor: Butamax(TM) Advanced Biofuels LLC
-
Publication number: 20140038833Abstract: Disclosed are data processing and analysis methods for gene expression data for identifying endogenous reference genes and a composition for the quantitative analysis of gene expression, comprising a pair of primers and/or probes useful in amplifying the identified endogenous reference genes. Introduced with the concepts of “Zero's proportion” and CV, the method allows different datasets to be integrally analyzed, thereby searching for novel reference genes. By the method, 2,087 genes are first found as housekeeping genes which are expressed in most tissues, and the usefulness thereof in the relative quantification of different target genes is determined by analyzing their expression stability. Of the 2,087 genes, 13 genes show higher expression stability with lower expression levels across a wide range of samples than traditional reference genes such as GAPDH and ACTS, and therefore are suitable for the normalization of universal genes having relatively low expression levels.Type: ApplicationFiled: September 28, 2012Publication date: February 6, 2014Applicant: SNU R&DB FOUNDATIONInventors: Young Kee Shin, Mi Jeong Kwon, En Sel Oh, Yong Ho In, Sang Seok Koh
-
Publication number: 20140038294Abstract: Systems and methods are provided for defining a nucleic acid construct for integration at locus L of an organism. Nucleic acid requests are received, each such request specifying a genetic change to L. The request are expanded into component polynucleotides which are then arranged into {AR1, . . . , ARm} different arrangements, each ARi in {AR1, . . . , ARm} defining a different arrangement of the component polynucleotides. A score Si for each ARi in {AR1, . . . , ARm} is determined based on whether source constructs encoding a portion of ARi are physically present. An ARf in {AR1, . . . , ARm} is selected based on the score for ARf. Primer pairs are calculated to amplify the portions of ARf not represented in the source constructs. The portions of ARf amplified by the primer pairs and the portions of ARf in the source constructs, ordered by ARf, define the nucleic acid construct.Type: ApplicationFiled: October 11, 2012Publication date: February 6, 2014Applicant: Amyris Biotechnologies, Inc.Inventors: Darren M. Platt, Michael W. Bissell, Sunil S. Chandran, Brian L. Hawthorne, Erik Jedediah Dean, Christopher Dolan